Progressive multifocal leukoencephalopathy associated with carbamazepine -: induced immune dysfunction and recovery after carbamazepine cessation

Sarah Perrott, Qaisar Imran Khan, Carl E Counsell, Angus D Macleod

Research output: Contribution to journalArticlepeer-review

Abstract

A patient with epilepsy on carbamazepine developed a rapidly progressive cerebellar syndrome. Serial MRI showed progressive posterior fossa T2/fluid attenuated inversion recovery hyperintensity with gadolinium enhancement. Standard cerebrospinal fluid (CSF) analysis was normal. Detection of John Cunningham virus DNA in the CSF confirmed progressive multifocal leukoencephalopathy (PML). The only evidence of immune disfunction was hypogammaglobulinaemia and longstanding lymphopenia. After cessation of carbamazepine, the lymphocyte count and immunoglobulin levels returned to normal and the PML resolved, with good clinical recovery. No specific treatments for PML were given. We hypothesise that PML in this case was due to carbamazepine-induced prolonged mild immunosuppression with reconstitution of the immune system after carbamazepine cessation, resulting in recovery from PML. Effects of anticonvulsants on immune function and infection risk may contribute to epilepsy-related morbidity and mortality. Further investigation is needed to determine the frequency of immune dysfunction and infections in patients treated with anticonvulsants such as carbamazepine and whether interventions could reduce infection risk.

Original languageEnglish
Article numbere255119
JournalBMJ Case Reports
Volume16
Issue number7
Early online date6 Jul 2023
DOIs
Publication statusPublished - 6 Jul 2023

Keywords

  • brain stem / cerebellum
  • drugs: CNS (not psychiatric)
  • infection (neurology)
  • neurology (drugs and medicines)

Fingerprint

Dive into the research topics of 'Progressive multifocal leukoencephalopathy associated with carbamazepine -: induced immune dysfunction and recovery after carbamazepine cessation'. Together they form a unique fingerprint.

Cite this